Evidence map›Paper›PMID 39211023›Full record

ReviewMediterranean journal of rheumatology2024

Current Approaches to Prevent or Reverse Microbiome Dysbiosis in Chronic Inflammatory Rheumatic Diseases.

Jan René Nkeck, Ange Larissa Tchuisseu-Kwangoua, Adeline Pelda, Wilson Chia Tamko, Saquinatou Hamadjoda, Doris Bibi Essama, Baudelaire Fojo, Moustapha Niasse, Saïdou Diallo, Madeleine Ngandeu-Singwé

Abstract readReview
In one paragraph

Review in Mediterranean journal of rheumatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jan René NkeckYaoundé Rheumatology Research Team, Yaoundé, Cameroon.
Ange Larissa Tchuisseu-KwangouaYaoundé Rheumatology Research Team, Yaoundé, Cameroon.
Adeline PeldaYaoundé Rheumatology Research Team, Yaoundé, Cameroon.
Wilson Chia TamkoYaoundé Rheumatology Research Team, Yaoundé, Cameroon.
Saquinatou HamadjodaYaoundé Rheumatology Research Team, Yaoundé, Cameroon.
Doris Bibi EssamaDepartment of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Baudelaire FojoYaoundé Rheumatology Research Team, Yaoundé, Cameroon.
Moustapha NiasseDepartment of Rheumatology, Dantec Teaching Hospital, Cheikh Anta Diop University, Dakar, Senegal.
Saïdou DialloDepartment of Rheumatology, Dantec Teaching Hospital, Cheikh Anta Diop University, Dakar, Senegal.
Madeleine Ngandeu-SingwéYaoundé Rheumatology Research Team, Yaoundé, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in knowledge of the microbiome and its relationship with the immune system have led to a better understanding of the pathogenesis of chronic inflammatory rheumatic diseases (CIRD). Indeed, the microbiome dysbiosis now occupies a particular place with implications for the determinism and clinical expression of CIRD, as well as the therapeutic response of affected patients. Several approaches exist to limit the impact of the microbiome during CIRD. This review aimed to present current strategies to prevent or reverse microbiome dysbiosis based on existing knowledge, in order to provide practical information to healthcare professionals treating patients suffering from CIRD.

Indexed as

chronic inflammatory rheumatic diseasesdysbiosismicrobiomepreventionsub-Saharan Africatreatment

Identifiers

PMID39211023
PMCPMC11350408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.